Skip to main content
Log in

Metabolomics Study on the Effects of Jieduquyuziyin Prescription on Systemic Lupus Erythematosus Mice by LC-Q-TOF/MS

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

A metabolomics approach was applied to study the metabolites characters of systemic lupus erythematosus (SLE) and therapeutical effects of jieduquyuziyin prescription (JP). High performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (HPLC-Q-TOF/MS) in positive mode was employed to analyze urine specimens of the SLE model mice (MRL/lpr) group, prednisone acetate (PA)-treated SLE mice group, JP-treated SLE mice group, and control group (C57BL/6 J). Software of Mass Hunter and Mass Profiler Professional (MPP) were used to process the data. Multivariate statistical analysis of principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) were applied to recognize the data pattern. PCA result showed that there were obvious disorders of amino acid metabolism in SLE model. Ten compounds have significant contributions to classification were identified as differential metabolites, such as glycine, pantetheine, and phenylpyruvic acid. Metabolism of phenylalanine tended to recover to the normal state after treatment with PA. The changes of glycine, phenylalanine, and tryptophan in SLE mice showed some alleviation in JP-treated SLE group. Thus, the JP has a good therapeutic effect on the SLE model mice by regulating the dysfunctions of amino acid metabolism. These results may be helpful to further understand the pathological mechanisms of SLE from the whole metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110–2121

    Article  CAS  Google Scholar 

  2. Uchida K, Nitta K (2012) Recent advances in the treatment of lupus nephritis. Clin Exp Nephrol 16:202–213

    Article  CAS  Google Scholar 

  3. Parikh S, Hebert L, Rovin B (2011) Protecting the kidneys in lupus nephritis. Int J Clin Rheumatol 6(5):529–546

    Article  Google Scholar 

  4. Xu XF, Xiang ZY, Qu HR et al (2011) Clinical research of treatment of ziyinjieduquyu methods on the systemic lupus erythematosus. J New Chin Med 43:51–53

    Google Scholar 

  5. Wen CP, Fan YS, Li YW et al (2007) 34 cases of the jieduquyuziyin methods treatment of thrombocytopenia of systemic lupus erythematosus. J Tradit Chin Med 48:529–530

    Google Scholar 

  6. Wen CP, Fan YS, Li XY et al (2007) Investigation on the effect of traditional Chinese medical jieduquyuziyin methods on the quality of life with systemic lupus erythematosus. J Tradit Chin Med Pharm 25:1599–1602

    Google Scholar 

  7. Nicholson JK, Lindon JC, Holmes E (1999) ‘Metabolomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189

    Article  CAS  Google Scholar 

  8. Weckwerth W (2003) Metabolomics in systems biology. Annu Rev Plant Biol 54:669–689

    Article  CAS  Google Scholar 

  9. Vuckovic D (2012) Current trends and challenges in sample preparation for global metabolomics using liquid chromatography–mass spectrometry. Anal Bioanal Chem 403:1523–1548

    Article  CAS  Google Scholar 

  10. Liang XP, Chen X, Liang QL et al (2011) Metabonomic study of Chinese medicine Shuanglong formula as an effective treatment for myocardial infarction in rats. J Proteome Res 10:790–799

    Article  CAS  Google Scholar 

  11. Yan G, Zhang YF, Shi XZ et al (2010) Effect of traditional Chinese medicine Berberine on type 2 diabetes based on comprehensive metabolomics. Talanta 81:766–772

    Article  Google Scholar 

  12. Schorlemme HU, Kanzy EJ, Langner KD et al (1993) Immunoregulation of SLE-like disease by the IL-receptor: disease modifying activity on BDF 1 hybrid mice and MRL autoimmune mice. Inflamm Res 39:117–120

    Google Scholar 

  13. Reilly CM, Gilkeson GS (2002) Use of genetic knockouts to modulate disease expression in a murine model of Lupus, MRL/lpr mice. Immunol Res 25:143–153

    Article  CAS  Google Scholar 

  14. Gall S, Legrand J, Benbijja M et al (2012) Loss of P2X7 receptor plasma membrane expression and function in pathogenic B220 + double-negative T lymphocytes of autoimmune MRL/lpr mice. PLoS ONE 7:e52116

    Article  Google Scholar 

  15. Jiang C, Zhao ML, Diaz M et al (2008) Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis. Immunology 126:102–113

    Article  Google Scholar 

  16. Judith M, Selena E, Richard H et al (2010) The evolution of partial least squares models and related chemometric approaches in metabolomics and metabolic phenotyping. J Chemom 24:636–649

    Article  Google Scholar 

  17. Theodore R, Joseph C, Li XD et al (2008) Molecular formula and METLIN personal metabolite database matching applied to the identification of compounds generated by LC/TOF-MS. J Biomol Tech 19:258–266

    Google Scholar 

  18. Wishart DS, Tzur D, Knox C et al (2007) HMDB: the human metabolome database. Nucleic Acids Res 35:521–526

    Article  Google Scholar 

  19. Treadwell EL, Cohen P, Williams D et al (1993) MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus. J Immunol 150:695–699

    CAS  Google Scholar 

  20. Ding XH, Yu Y (2012) Serum metabolomics study of systemic lupus erythematosus by rapid resolution liquid chromatography coupled with Q-TOF mass spectrometry. Int Conf Biomed Eng Biotechnol 2012:507–510

    Google Scholar 

  21. Miller GW, Lock EA, Schnellmann RG (1994) Strychnine and glycine protect renal proximal tubules from various nephrotoxicants and act in the late phase of necrotic cell injury. Toxicol Appl Pharmacol 125:192–197

    Article  CAS  Google Scholar 

  22. Tijsen MJ, Peters SM, Bindels RJ et al (1997) Glycine protection against hypoxic injury in isolated rat proximal tubules: the role of proteases. Nephrol Dial Transplant 12:2549–2556

    Article  CAS  Google Scholar 

  23. Pérez-Torres I, Ibarra B, Soria-Castro E et al (2011) Effect of glycine on the cyclooxygenase pathway of the kidney arachidonic acid metabolism in a rat model of metabolic syndrome. Can J Physiol Pharmacol 89:899–910

    Article  Google Scholar 

  24. Alegre E, Sofía LA, Díaz L et al (2008) Study of the plasmatic levels of tryptophan and kynurenine throughout pregnancy. Clin Chim Acta 393:132–134

    Article  CAS  Google Scholar 

  25. Shunichi S (2012) Pathogenesis of SLE and aiCD4 T cell: new insight on autoimmunity. Joint Bone Spine 79:428–430

    Article  Google Scholar 

  26. Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4:762–774

    Article  CAS  Google Scholar 

  27. LeRond S, Gonzalez A, Gonzalez AS et al (2005) Indoleamine 2, 3-dioxygenase and human leukocyte antigen G inhibit the T cell alloproliferative response through two independent pathways. Immunology 116:297–307

    Article  CAS  Google Scholar 

  28. Sas K, Robotka H, Toldi J et al (2007) Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system with focus on neurodegenerative disorders. Neurol Sci 257:221–239

    Article  CAS  Google Scholar 

  29. Boilard E, Blanco P, Nigrovic PA (2012) Platelets: active players in the pathogenesis of arthritis and SLE. Nat Rev Rheumatol 8:534–542

    Article  CAS  Google Scholar 

  30. Horvath Z, Vecse L (2009) Current medical aspects of pantethine. Ideggyogy Sz 62:220–229

    Google Scholar 

Download references

Acknowledgments

This study has been supported by the National Natural Science Foundation of China (NO.81001515), Research Fund for the Doctoral Program of Higher Education of China (NO.20093322120001)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xing-hong Ding.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, Jb., Jiang, Fs., Gu, Hc. et al. Metabolomics Study on the Effects of Jieduquyuziyin Prescription on Systemic Lupus Erythematosus Mice by LC-Q-TOF/MS. Chromatographia 76, 791–800 (2013). https://doi.org/10.1007/s10337-013-2476-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-013-2476-9

Keywords

Navigation